These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8541169)

  • 1. Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation.
    Stafford PJ; Cooper J; de Bono DP; Vincent R; Garratt CJ
    Br Heart J; 1995 Dec; 74(6):636-40. PubMed ID: 8541169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation.
    Stafford PJ; Robinson D; Vincent R
    Br Heart J; 1995 Oct; 74(4):413-8. PubMed ID: 7488457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of sotalol hydrochloride therapy on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Telichowski A; Banasiak W; Wiech K; Zeborowski J; Pieróg M; Ponikowski P; Kałka D; Lacheta W; Fuglewicz A; Telichowski C
    Pol Merkur Lekarski; 1996 Nov; 1(5):303-9. PubMed ID: 9273201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
    Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
    Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.
    Steeds RP; Birchall AS; Smith M; Channer KS
    Heart; 1999 Aug; 82(2):170-5. PubMed ID: 10409530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency analysis of the P wave: comparative techniques.
    Stafford P; Denbigh P; Vincent R
    Pacing Clin Electrophysiol; 1995 Feb; 18(2):261-70. PubMed ID: 7731874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation.
    Yamada T; Fukunami M; Shimonagata T; Kumagai K; Sanada S; Ogita H; Asano Y; Hori M; Hoki N
    Eur Heart J; 1999 Feb; 20(3):211-20. PubMed ID: 10082154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol.
    Weber UK; Osswald S; Huber M; Buser P; Skarvan K; Stulz P; Schmidhauser C; Pfisterer M
    Eur Heart J; 1998 May; 19(5):794-800. PubMed ID: 9717015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of the signal averaged P wave: time and frequency domain analysis.
    Stafford PJ; Cooper J; Fothergill J; Schlindwein F; deBono DP; Garratt CJ
    Heart; 1997 May; 77(5):412-6. PubMed ID: 9196409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioversion with sotalol in selected patients with vagally and adrenergically mediated paroxysmal atrial fibrillation.
    Yeşil M; Bayata S; Postaci N; Yücel O; Aslan O
    Angiology; 1999 Sep; 50(9):729-33. PubMed ID: 10496499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of propafenone hydrochloride on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Telichowski A; Banasiak W; Ponikowski P; Wiech K; Zebrowski J; Pieróg M; Kałka D; Lacheta W; Fuglewicz A; Molenda W
    Pol Arch Med Wewn; 1995 Aug; 94(2):132-43. PubMed ID: 8596748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
    Kubara I; Ikeda H; Hiraki T; Yoshida T; Ohga M; Imaizumi T
    J Cardiovasc Electrophysiol; 1999 May; 10(5):670-9. PubMed ID: 10355923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F; Candinas R; Frielingsdorf J
    Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.
    Cecchi F; Montereggi A; Olivotto I; Marconi P; Dolara A; Maron BJ
    Heart; 1997 Jul; 78(1):44-9. PubMed ID: 9290401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrotemporal and spectral turbulence analysis of the signal-averaged P wave in paroxysmal atrial fibrillation.
    Stafford PJ; Vincent R
    J Electrocardiol; 1997 Apr; 30(2):79-86. PubMed ID: 9141600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.